Internal Medicine
Dyspepsia: A stepwise approach to evaluation and management.
19 Jan, 2022 | 08:24h | UTCDyspepsia: A stepwise approach to evaluation and management – Family Practice
Opinion: Five tips for becoming an ideal general hospitalist.
19 Jan, 2022 | 08:23h | UTCFive Tips for Becoming an Ideal General Hospitalist – International Journal of General Medicine
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
18 Jan, 2022 | 09:59h | UTCSee also:
Israeli trial, world’s first, finds 4th dose ‘not good enough’ against Omicron – The Times of Israel
Israel study: 4th vaccine shows limited results with omicron – MedicalXpress
COVID-19 updated evidence: a Cochrane round-up.
18 Jan, 2022 | 09:53h | UTCCOVID-19 evidence: a Cochrane round-up – Cochrane Library
Time to upgrade from cloth and surgical masks to respirators? Your questions answered.
18 Jan, 2022 | 09:48h | UTCSee also: The CDC updated its mask guidelines. What to know about ‘the highest level of protection’ – CNN
Study raises doubts about rapid Covid tests’ reliability in early days after infection.
18 Jan, 2022 | 09:51h | UTCStudy raises doubts about rapid Covid tests’ reliability in early days after infection – STAT
Original Article (preprint): Discordant SARS-CoV-2 PCR and Rapid Antigen Test Results When Infectious: A December 2021 Occupational Case Series – medRxiv
Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.
18 Jan, 2022 | 09:41h | UTC
Perspective | Post-acute neurological consequences of COVID-19: an unequal burden – “COVID-19 and its neurological consequences particularly burden marginalized communities, and so can only be effectively treated by advancing health equity”.
18 Jan, 2022 | 09:44h | UTCPost-acute neurological consequences of COVID-19: an unequal burden – Nature Medicine
Pro-Con Debate: Cardiac Troponin measurement as part of routine follow-up of myocardial damage following noncardiac surgery.
18 Jan, 2022 | 09:36h | UTC
ACP Guideline: Diagnosis and management of acute left-sided colonic diverticulitis.
18 Jan, 2022 | 09:38h | UTCRelated Systematic Reviews:
Annals Video Summary: Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine
News Release: ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis – American College of Physicians
Podcast: Lower Extremity Edema Pearls.
18 Jan, 2022 | 09:33h | UTC#316 Lower Extremity Edema – The Curbsiders
Review: Myocardial infarction with non-obstructive coronary artery disease.
18 Jan, 2022 | 09:24h | UTCMyocardial infarction with non-obstructive coronary artery disease – EuroIntervention
Related:
MINOCA from A to Z – American College of Cardiology
A national cohort study in Sweden showed pregnancy complications (preeclampsia or eclampsia, gestational hypertension, gestational diabetes, preterm birth, small for gestational age, and stillbirth) are associated with increased risk of cardiovascular disease later in life.
18 Jan, 2022 | 09:26h | UTC
Cohort study: In patients who underwent bariatric surgery, those submitted to gastric bypass were slightly more likely to remain free of obesity-related medications during follow-up compared with those who underwent sleeve gastrectomy.
18 Jan, 2022 | 09:31h | UTCMedication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass – JAMA Surgery (link to abstract – $ for full-text)
Commentary: Gastric Bypass Tied to Modest Shift in Need for Comorbidity Meds – MedPage Today (free registration required)
Commentary on Twitter
Among patients taking medications for obesity-related conditions before bariatric surgery, gastric bypass and sleeve gastrectomy both had high rates of medication discontinuation after surgery, however gastric bypass was slightly more effective. https://t.co/JrIaYk9dZT pic.twitter.com/BAbaGINCpb
— JAMA Surgery (@JAMASurgery) January 12, 2022
WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19.
17 Jan, 2022 | 00:48h | UTCNews release: WHO recommends two new drugs to treat COVID-19 – World Health Organization
Infographic with the updated recommendations: A living WHO guideline on drugs for covid-19 – The BMJ
Commentaries:
Commentary on Twitter (thread – click for more)
WHO has also conditionally recommended the use of sotrovimab for treating mild or moderate #COVID19 in patients who are at high risk of hospitalization: patients who are older, immunocompromised, with underlying conditions & those unvaccinated https://t.co/UAc21Wgxbl https://t.co/Z39mSKrOv5
— World Health Organization (WHO) (@WHO) January 14, 2022
Viewpoint: COVID-19 therapeutics for nonhospitalized patients.
17 Jan, 2022 | 00:31h | UTCCOVID-19 Therapeutics for Nonhospitalized Patients – JAMA
Editorial: Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management – JAMA
One in 10 people may still be infectious for COVID after 10 days, new research indicates.
17 Jan, 2022 | 00:34h | UTCNews Release: One in 10 people may still be infectious for COVID after 10 days, new research indicates – University of Exeter
2022 Guidelines on the management of chronic venous disease of the lower limbs.
16 Jan, 2022 | 23:22h | UTC
RCT: Oral Vitamin D supplementation (60.000 IU per month) did not reduce mortality in patients 60 years or older (unscreened individuals in Australia, many without insufficiency, average 30ng/mL). Exploratory analyses pointed towards an increased risk of death from cancer.
16 Jan, 2022 | 23:13h | UTCThe D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Related:
Randomized Trial: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Meta-Analysis: Vitamin D Not Effective for Cardiovascular Disease Prevention
Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases
Research: Circulating vitamin D concentration and risk of seven cancers
Research: Vitamin D and risk of total and site specific cancers
ERAS Guidelines for perioperative care in bariatric surgery.
16 Jan, 2022 | 23:21h | UTCRelated: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter
#VisualAbstract ➡️ Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update@Jasosamd @iss_sic
🆓🔗https://t.co/HknWwLUjCZ pic.twitter.com/amhszadwup— World Journal of Surgery (@WorldJSurg) January 5, 2022
RCT: Vitamin D supplementation is not beneficial for the prevention of cardiovascular disease and cancer.
16 Jan, 2022 | 23:11h | UTCNews Release: Five years of high-dose vitamin D did not affect incidence of cardiovascular disease or cancer – University of Eastern Finland
Related:
Randomized Trial: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Meta-Analysis: Vitamin D Not Effective for Cardiovascular Disease Prevention
Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases
Research: Circulating vitamin D concentration and risk of seven cancers
Research: Vitamin D and risk of total and site specific cancers
Perspective: Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age.
16 Jan, 2022 | 22:53h | UTCCommentaries:
Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’ – Florida Atlantic University
Preventive Aspirin Should Be Based on Benefit, Not Age – HealthDay
Cluster randomized trial: no added value of duloxetine for patients with chronic pain due to hip or knee osteoarthritis.
16 Jan, 2022 | 22:59h | UTC
Analysis: Sarcopenia: early prevention or overdiagnosis?
16 Jan, 2022 | 22:48h | UTCSarcopenia: early prevention or overdiagnosis? – The BMJ
Related: Overdiagnosis: it’s official – the term is now included in the medical subject headings (MeSH) vocabulary. (several articles on the subject)
Commentary from the author on Twitter
We have a new diagnosis! 2 billion people may turn into patients with sarcopenia. Despite no evidence to justify why we should diagnose elderly people. My latest article in @bmj_latest with @drjohnbrodersen and JBülow. #overdiagnosis #sarcopenia #EBM https://t.co/mNFxmuz4U1
— Christoffer Bjerre Haase (@BjerreHaase) January 13, 2022
Review | Travelling with heart failure: risk assessment and practical recommendations.
16 Jan, 2022 | 22:46h | UTCTravelling with heart failure: risk assessment and practical recommendations – Nature Reviews Cardiology (if this link is paywalled, try this one)